Aminohippurate Sodium

CHEMBL1200365 Phase 4 承認済み Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
216.2 g/mol
LogP
Phase
4

A compound used exclusively as a diagnostic agent to measure kidney blood flow and the secretory function of the renal tubules. When injected into the blood, it is efficiently filtered and secreted by the kidneys at a rate that allows calculation of renal plasma flow and tubular secretion capacity.

分子量

216.1700 g/mol

TPSA

95.30 Ų

治療領域

作用機序

Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

機序

Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.

2D構造

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

Nc1ccc(C(=O)NCC(=O)[O-])cc1.[Na+]

InChI

InChI=1S/C9H10N2O3.Na/c10-7-3-1-6(2-4-7)9(14)11-5-8(12)13;/h1-4H,5,10H2,(H,11,14)(H,12,13);/q;+1/p-1

Molecular Formula

C9H9N2NaO3

HBD / HBA

2 / 4

回転可能結合数

3

重原子数

15

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

A compound used exclusively as a diagnostic agent to measure kidney blood flow and the secretory function of the renal tubules. When injected into the blood, it is efficiently filtered and secreted by the kidneys at a rate that allows calculation of renal plasma flow and tubular secretion capacity.

Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.

Yes, Aminohippurate Sodium is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200365. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 443971. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.